The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium 4-(((R)-(1-(4-(3,4-dihydroisoquinolin-2(1H)-yl)-4-oxobutyl)-1H-tetrazol-5-yl)(thiophen-2-yl)methyl)amino)-3-hydroxybutanoate ID: ALA5208650
PubChem CID: 168296353
Max Phase: Preclinical
Molecular Formula: C23H27N6NaO4S
Molecular Weight: 484.58
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C([O-])CC(O)CN[C@@H](c1cccs1)c1nnnn1CCCC(=O)N1CCc2ccccc2C1.[Na+]
Standard InChI: InChI=1S/C23H28N6O4S.Na/c30-18(13-21(32)33)14-24-22(19-7-4-12-34-19)23-25-26-27-29(23)10-3-8-20(31)28-11-9-16-5-1-2-6-17(16)15-28;/h1-2,4-7,12,18,22,24,30H,3,8-11,13-15H2,(H,32,33);/q;+1/p-1/t18?,22-;/m0./s1
Standard InChI Key: WIWSDJSFSZLHKL-KJIPLLCSSA-M
Molfile:
RDKit 2D
35 37 0 0 0 0 0 0 0 0999 V2000
-4.0998 -1.4181 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
0.8200 2.0718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1525 2.5567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4074 3.3414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2325 3.3414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4874 2.5567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6444 2.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8580 1.5461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6550 1.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8685 0.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6656 0.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8791 -0.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6762 -0.6886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2957 -1.0585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2850 -0.0478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8200 1.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 0.8341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 0.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -0.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -1.2286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 -1.6413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 -2.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -2.8790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 -2.4665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 -1.6413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2494 -3.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9661 -4.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6762 -3.7035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6759 -2.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 0.0089 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2279 2.9266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0424 2.7976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4169 3.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8337 4.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0988 3.7412 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 2 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
10 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
21 20 1 0
22 21 1 0
23 22 2 0
24 23 1 0
25 24 1 0
20 25 1 0
23 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
22 29 1 0
19 30 2 0
7 31 1 1
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 1 0
M CHG 2 1 1 13 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.58Molecular Weight (Monoisotopic): 484.1893AlogP: 1.61#Rotatable Bonds: 11Polar Surface Area: 133.47Molecular Species: ACIDHBA: 9HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.90CX Basic pKa: 6.83CX LogP: -1.04CX LogD: -1.59Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.37Np Likeness Score: -1.69
References 1. Ulgheri F, Spanu P, Deligia F, Loriga G, Fuggetta MP, de Haan I, Chandgudge A, Groves M, Domling A.. (2022) Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders., 229 [PMID:34823899 ] [10.1016/j.ejmech.2021.114002 ]